documents: FDA-2026-D-8693-0002

Federal regulatory documents currently open for public comment. ⚠ Derive comment deadlines from comment_end_datetime converted to America/New_York, never from comment_end_date, which is mid-correction and may be one day late (DataDawn queue #498).

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	agency_id	docket_id	title	document_type	subtype	posted_date	posted_year	posted_month	comment_start_date	comment_end_date	comment_end_datetime	perpetual_docket	last_modified	fr_doc_num	open_for_comment	withdrawn	object_id
FDA-2026-D-8693-0002	FDA	FDA-2026-D-8693	Pharmacokinetics in Patients with Impaired Hepatic Function: Study Design, Data Analysis, and Impact on Dosage; Guidance for Industry; Draft Guidance for Industry	Other	Guidance	2026-09-02	2026	9	2026-09-02	2026-12-01	2026-12-02 04:59:59	0	2026-09-03 00:56:30		1	0	09000064b94bc729